Takeo Hata

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Rheumatoid Arthritis

Health Insurance

Top Venues

British journal of clinical pharmacology

Pharmacotherapy

Clinical drug investigation

Therapeutics and clinical risk management

This page only lists publications with an associated author ORCID identifier.

Publications

Ryosuke Ota, Atsushi Hirata, Takeo Hata, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Incidence of serious infections in the working-age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor-α inhibitors and interleukin-6 inhibitors: A nationwide retrospective cohort study. Pharmacotherapy 44 (7) (2024)
Ryosuke Ota, Atsushi Hirata, Takeo Hata, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Incidence of serious infections in the working-age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor-α inhibitors and interleukin-6 inhibitors: A nationwide retrospective cohort study. Pharmacotherapy (2024)
Noriaki Kataoka, Takeo Hata, Kouichi Hosomi, Atsushi Hirata, Satoe Fujiwara, Emi Goto, Masami Nishihara, Masahide Ohmichi, Masashi Neo
Predictors of olaparib discontinuation owing to adverse drug events in patients with ovarian, peritoneal, or fallopian tube cancer: a retrospective observational study. Journal of chemotherapy (Florence, Italy) (2024)
Emi Goto, Takeo Hata, Masami Nishihara, Masashi Neo, Mitsuhiko Iwamoto, Kosei Kimura, Masahiro Goto, Yoshiyuki Rikitake
Preventive effect of dexamethasone premedication on the development of infusion-related reaction in breast cancer patients receiving trastuzumab. British journal of clinical pharmacology (2023)
Ryosuke Ota, Takeo Hata, Atsushi Hirata, Takeshi Hamada, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Risk of infection from glucocorticoid and methotrexate interaction in patients with rheumatoid arthritis using biologics: A retrospective cohort study. British journal of clinical pharmacology (2023)
Ryosuke Ota, Takeo Hata, Atsushi Hirata, Takeshi Hamada, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Risk of infection from glucocorticoid and methotrexate interaction in patients with rheumatoid arthritis using biologics: a retrospective cohort study. British journal of clinical pharmacology (2023)
Emi Goto, Takeo Hata, Masami Nishihara, Masashi Neo, Mitsuhiko Iwamoto, Kosei Kimura, Masahiro Goto, Yoshiyuki Rikitake
Preventive effects of dexamethasone premedication on the development of infusion-related reactions in breast cancer patients receiving trastuzumab. British journal of clinical pharmacology (2023)
Takeo Hata, Hitoshi Murao, Etsuko Nakagami-Yamaguchi, Yoko Yamaguchi, Hiromi Eguchi, Masami Nishihara, Masahiko Nitta, Eiichiro Ueda, Kazuhisa Uchiyama, Takahiro Katsumata
Factors affecting patient safety culture in a university hospital under the universal health insurance system: A cross-sectional study from Japan. Medicine 101 (45) (2022)
Takeo Hata, Hiroaki Shima, Masahiko Nitta, Eiichiro Ueda, Masami Nishihara, Kazuhisa Uchiyama, Takahiro Katsumata, Masashi Neo
The Relationship Between Duration of General Anesthesia and Postoperative Fall Risk During Hospital Stay in Orthopedic Patients. Journal of patient safety 18 (6) (2022)
Takeo Hata, Atsushi Hirata, Ryosuke Ota, Keiko Hosohata, Masami Nishihara, Masashi Neo, Takahiro Katsumata
Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database. Therapeutics and clinical risk management 18 (2022)
Atsushi Hirata, Ryosuke Ota, Takeo Hata, Takeshi Hamada, Masami Nishihara, Kazuhisa Uchiyama, Takahiro Katsumata
Prescribing Trends of Biologic Disease-Modifying Anti-rheumatic Drugs Using a Claims Database from 6 Million People in Japan. Clinical drug investigation 41 (11) (2021)